Products

Overview

The Immunologix Opportunity

Immunologix was created for the purpose of commercially marketing its proprietary technology of fully human antibodies within the therapeutic and research antibody fields. Our technology can be utilized in one of three ways:

Custom Antibody

To date, Immunologix has attempted and succeeded in the creation of fully human monoclonal antibodies against five different classes of antigen (Cancer, Toxin, Viral, Bacterial, Auto-Antigen). This proof of concept progress confirms the ability of the Immunologix platform to produce fully human monoclonal antibodies against any antigen target.

Technology Licensing

As an alternative to purchasing a custom antibody from Immunologix, a client partner may selectively in-license the proprietary use of our antibody generating technology for a specific antigen and therapeutic indication. Immunologix will partner with its clients based on current therapeutic products in the research and development phase or the development of new products aimed at biological targets provided by our partners.

Research Antibody

Immunologix can employ its technology to produce highly specific human monoclonal antibodies for utilization in the laboratory as research and development tools.

For specifics on services provided byy Immunologix, please contact us at info@immunologixinc.com